Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Granules India LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532482NSE Symbol: GRANULESP/E(TTM):36.6
ISIN Demat:INE101D01020Div & Yield %:0.27EPS(TTM):14.92
Book Value(Rs):146.2291832Market Cap ( Cr.):13249.71Face Value(Rs):1
    Change Company 
Date Headline
14-Nov-25 Granules India consolidated net profit rises 34.33% in the September 2025 quarter
14-Nov-25 Granules India standalone net profit rises 191.40% in the September 2025 quarter
11-Nov-25 Granules Life Sciences receives USFDA approval for its Hyderabad unit
11-Nov-25 Granules India's Hyderabad-based facility gets first U.S. FDA approval
07-Nov-25 Granules India Ltd - Granules India Limited - Analysts/Institutional Investor Meet/Con. Call Updates
05-Nov-25 Granules Pharmaceuticals Inc. concludes USFDA inspection
31-Oct-25 Granules India Ltd - Granules India Limited - Analysts/Institutional Investor Meet/Con. Call Updates
30-Oct-25 Granules India to conduct board meeting
29-Oct-25 Granules India gains after USFDA issues EIR for Hyderabad API facility
25-Sep-25 Granules India Ltd - Closure of Trading Window
<< < 1 2 3 4   > >>